Skip to main content

Advertisement

TableĀ 2 Summary statistics of RNA preparation, RNA sequencing, read mapping to the human GRCh37 and P. vivax P01 genomes, and sequence coverage, for 10 clinical isolates from vivax malaria patients taken from two regions: Ubon Ratchathani (UBT; North-East) and Yala (YL; South)

From: Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)

Isolate Total RNA (ng) RNA integrity number (RIN) Total read pairsa Pair reads mapped to human Percentage of reads mapped to human Pair reads mapped to P. vivax Percentage of reads mapped to P. vivax Mean sequence coverage
1 UBT3086 585.2 2 29,157,609 22,771,884 78.10 346,899 1.20 1.82
2 UBT3087 392 2.4 36,549,438 29,392,764 80.42 977,753 2.68 17.67
3 UBT3089 1498 2.3 30,083,802 23,272,992 77.36 3,035,144 10.09 78.52
4 UBT3090 719.6 2.3 30,397,809 22,226,523 73.12 3,267,128 10.75 17.59
5 UBT3091 504 2.3 28,550,673 18,312,289 64.14 6,388,456 22.38 42.07
6 YL3111 627.2 2.3 29,500,938 26,039,174 88.27 580,181 1.97 3.18
7 YL3112 1005.2 2.3 32,578,915 27,732,216 85.12 913,421 2.80 4.95
8 YL3113 280 2 26,853,921 21,654,627 80.64 209,249 0.78 1.07
9 YL3114 1470 2.8 31,860,822 27,764,327 87.14 350,337 1.10 1.88
10 YL3115 641.2 2.5 32,987,343 24,102,143 73.05 3,469,628 10.52 20.13
  1. aAfter adapter and quality trimming